BioCentury
ARTICLE | Clinical News

Autolymphocyte therapy: Filed Canadian IND

July 5, 1994 7:00 AM UTC

Cellcor Inc. (CLTX), Newton, Mass. Product: Autolymphocyte therapy in which patients' cells are removed and processed to activate killer and helper T cells Indication: Metastatic kidney cancer Status:...